We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The leptin/adiponectin ratio as prognostic marker for dyslipidemia during 1 year of follow-up in pediatric patients receiving kidney replacement therapy.
- Authors
Ángel Villasís-Keever, Miguel; Nallely Zurita-Cruz, Jessie; Serret-Montoya, Juana; Barbosa-Cortés, Lourdes; del Carmen Zepeda-Martínez, Claudia; Alegría-Torres, Gabriela; Sugei Barradas-Vázquez, Aly; Alonso-Flores, Sara; Hernández-Hernández, Carolina; Manuel-Apolinar, Leticia; Damasio-Santana, Leticia; Manuel Domínguez-Salgado, Juan
- Abstract
Background: leptin and adiponectin are associated with cardiovascular disease in chronic kidney disease (CKD) patients and could be useful prognostic factors. Objectives: to explore the usefulness of the leptin/adiponectin ratio (LAR) to predict the presence or worsening of dyslipidemia during 1 year of follow-up in children receiving kidney replacement therapy (KRT). Material and methods: a prospective cohort study was performed. Pediatric KRT patients aged between 8 and 17 years who were undergoing hemodialysis or peritoneal dialysis were included. At enrollment, the lipid profile, adiponectin and leptin levels, and somatometric measurements, including body fat percentage, were determined. At the one-year follow-up, the lipid profile was reassessed. Results: of the 70 patients included, the median age was 13 years, and there was no sex predominance (52.8 % males). At the end of fol)low-up, the patients were divided into three groups: those without dyslipidemia (WOD), those who developed or experienced worsening of their dyslipidemia (DWD) and those with persistent dyslipidemia (PD). A LAR > 0.85 (OR, 16.7) and body fat percentage (OR, 1.46) were associated with an increased risk of PD and DWD at 12 months, independently of urea level, BMI Z-score, benzafibrate treatment, CKD progression time, and replacement treatment. Conclusions: a LAR > 0.85 and fat body percentage at the beginning of follow-up were strongly associated with the presence, persistence or worsening of dyslipidemia at the 12-month follow-up in children with KRT.
- Subjects
RENAL replacement therapy; CHILD patients; CHRONIC kidney failure; FAT; PROGNOSIS; ADIPONECTIN; ADIPOKINES; LEPTIN; DYSLIPIDEMIA
- Publication
Nutrición Hospitalaria, 2022, Vol 39, Issue 6, p977
- ISSN
0212-1611
- Publication type
Article
- DOI
10.20960/nh.03890